# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-089342
Filing Date
2024-08-01
Accepted
2024-08-01 16:30:28
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | adpt-20240630.htm iXBRL | 10-Q | 2526870
2 | EX-31.1 | adpt-ex31_1.htm | EX-31.1 | 17185
3 | EX-31.2 | adpt-ex31_2.htm | EX-31.2 | 17179
4 | EX-32.1 | adpt-ex32_1.htm | EX-32.1 | 10252
5 | EX-32.2 | adpt-ex32_2.htm | EX-32.2 | 11423
| Complete submission text file | 0000950170-24-089342.txt |  | 10094829

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | adpt-20240630.xsd | EX-101.SCH | 1187129
80 | EXTRACTED XBRL INSTANCE DOCUMENT | adpt-20240630_htm.xml | XML | 2091445

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 241167234
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)